AbilityMade

Australia has 35% of the number of orthotists & prosthetists required to meet this country's needs (AOPA, 2012). We create technologies for the P&O industry to increase throughput and enhance patient experience. We've developed the world's fastest central fabrication service, to help P&O practitioners see more patients and scale up their practice. Our custom-made AFOs combine the cost of traditional plastics, with the speed and precision of 3D printing. Leveraging recent advances in 3D printing technology, our AFOs achieve the same mechanical properties of polypropylene and can be heated, molded and cut just like polypropylene. Our clinically-proven digital scanner is the fastest in the P&O industry, and can capture a patient's leg instantaneously. Our cloud-based app lets the orthotist design the AFO and submit the prescription online, making us the world's first CAD/CAM-free central fabrication service. To find out more about how we can help you see more patients, visit www.abilitymade.com or email us on hello@abilitymade.com.

Factor Therapeutics Ltd

Factor Therapeutics is an Australian biotechnology company pursuing the development and commercialisation of advanced wound care therapeutics. The Company’s lead programme, VF001, is a targeted growth factor that is being developed to treat venous leg ulcers (VLUs). Chronic wounds, such as VLUs, are common, painful and debilitating – a silent epidemic. Factor Therapeutics is a public company traded on the Australian Securities Exchange (ASX:FTT).

CELLESTIS LIMITED

DeNova Sciences Pte Limited

DeNova Sciences Pte. Limited is a Contract Research Organisation specialising in Dermatology Solution. Our tailorable testing solution utilize in vitro 3D skin and fresh ASIAN human skin explants to match the industry's research and commercialisation needs in One Stop Platform. These platforms help to address the increasing demand from personal care and nutrition industry on product efficacy and claim. Our services are not limited to only product testing but also in personalised outsourced R&D, product commercialisation and regulation consultancy for personal care products. With years of experience, DeNova has collaborated with many industry leaders and renowned research institutes to improve our technologies and innovative capabilities to ensure premium service for all our clients.

Exogen Biotechnology, Inc.

Exogen Biotechnology is a Berkeley-based healthcare startup dedicated to quantifying DNA damage and assessing cellular DNA repair capacities. Over 40% of the US population will be diagnosed with cancer and doctors desperately need a way to identify at risk cancer patients and stratify cancer patients for various treatment options. Exogen Bio has developed a technology capable of identifying novel DNA prognostic markers that allows clinicians to better prevent and treat cancer.